Pushback against a decades-old federal program that provides savings on prescription drugs to certain hospitals and health ...

Minnesota providers participating in the federal 340B Drug Pricing Program generated at least $630 million in net revenue in 2023, according to a new report from the state Department of Health.

The Minnesota Department of Health recently unveiled a pivotal report on the 340B drug pricing program, which provides insight into how the program’s financial benefits are being utilized by ...

The Minnesota Department of Health has released data detailing more than $600 million in extra revenue that hospitals received from a program known as “340B,” which exists to help safety-net ...

In its zeal to shrink the federal government, will the coming Trump administration disrupt a discount drug program that underpins the rural hospitals serving the communities that gave him their ...

The Kings are set to match up against the Minnesota Timberwolves on Wednesday, as the two Western Conference foes face off for the third time this season. The Timberwolves have already beaten the ...

The federal 340B Drug Pricing Program — a noble idea first enacted in 1992 — needs to be brought back into the shop for retooling. And now is the perfect time, with a new administration taking the ...

Minnesota releases a report on the 340B Drug Pricing Program, highlighting the need for transparency in healthcare economics.

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound ...

Sanofi plans to phase in its model for different 340B-eligible providers starting early next year. The rebates would apply to 25 drugs, including Dupixent, an injectable used to treat inflammatory ...